240 results match your criteria: "Hospital Rangueil[Affiliation]"
Background: Initial clinical studies of pulsed field ablation (PFA) to treat atrial fibrillation (AF) indicated a >90% durability rate of pulmonary vein isolation (PVI). However, these studies were largely conducted in single centers and involved a limited number of operators. The electrophysiological findings and outcomes in patients undergoing repeat ablation after an initial PF ablation for AF are incompletely understood.
View Article and Find Full Text PDFHeart Rhythm
September 2024
University Hospital Rangueil, Toulouse, France. Electronic address:
J Am Coll Cardiol
July 2024
Department of Cardiology, University Hospital Rangueil, Toulouse, France; I2MC, INSERM UMR 1297, Toulouse, France.
JACC Clin Electrophysiol
May 2024
Icahn School of Medicine at Mount Sinai, New York, NY, USA;; Cardiology Department, Na Homolce Hospital, Homolka Hospital, Prague, Czechia;. Electronic address:
Background: Atrial fibrillation (AF) and heart failure (HF) coexist, increasing morbidity and mortality. Studies have demonstrated improved outcomes following AF ablation in HF patients with reduced ejection fraction (EF).
Objective: To assess the outcomes of pulsed-field ablation (PFA) in HF.
JACC Clin Electrophysiol
May 2024
Icahn School of Medicine at Mount Sinai, New York, New York, USA; Cardiology Department, Na Homolce Hospital, Homolka Hospital, Prague, Czech Republic. Electronic address:
Background: Atrial fibrillation (AF) and heart failure (HF) coexist, increasing morbidity and mortality. Studies have demonstrated improved outcomes following AF ablation in HF patients with reduced ejection fraction (EF).
Objective: This study sought to assess the outcomes of pulsed field ablation (PFA) in HF.
Europace
May 2024
IHU LIRYC, University Bordeaux, CHU Bordeaux, Bordeaux, France.
Europace
March 2024
Hospital São Vicente - Rede Dor, Department of Cardiology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
EuroIntervention
April 2024
Columbia University Medical Center/NewYork-Presbyterian Hospital, The Cardiovascular Research Foundation, New York, NY, USA.
Arch Cardiovasc Dis
April 2024
Department of Cardiology, University Hospital Rangueil, 31059 Toulouse, France; I2MC, Inserm UMR 1297, 31432 Toulouse, France. Electronic address:
Eur J Vasc Endovasc Surg
July 2024
Department of Vascular Surgery, University Hospital Rangueil, Toulouse, France.
JACC Clin Electrophysiol
May 2024
Icahn School of Medicine at Mount Sinai, New York, New York, USA; Cardiology Department, Na Homolce Hospital, Homolka Hospital, Prague, Czech Republic. Electronic address:
Arch Cardiovasc Dis
March 2024
Cardiology Department, Grenoble-Alpes University, University Hospital, 38043 Grenoble, France.
Sustainability in healthcare, particularly within the domain of cardiac electrophysiology, assumes paramount importance for the near future. The escalating environmental constraints encountered necessitate a proactive approach. This position paper aims to raise awareness among physicians, spark critical inquiry and identify potential solutions to enhance the sustainability of our practice.
View Article and Find Full Text PDFJACC Clin Electrophysiol
March 2024
Section of Electrophysiology, Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. Electronic address:
Background: Desmoplakin (DSP) pathogenic variants are rare causes of arrhythmogenic cardiomyopathy and often involve the right and left ventricles. Ventricular tachycardia (VT) ablations may be required in these patients, but procedural characteristics have not been reported.
Objectives: In this study, the authors sought to report a multicenter experience of VT ablation in patients with DSP pathogenic variants.
Sensors (Basel)
November 2023
Department of Medical Sciences, University of Turin, 10124 Turin, Italy.
Orphanet J Rare Dis
November 2023
Pfizer Inc, New York, NY, USA.
Ann Rheum Dis
January 2024
Department of Internal Medicine, National Reference Center for Rare Systemic Autoimmune Diseases, AP-HP.Centre, Hospital Cochin, Paris, France
JAMA Cardiol
December 2023
Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, New York.
Importance: Previous studies evaluating the association of patient sex with clinical outcomes using conventional thermal ablative modalities for atrial fibrillation (AF) such as radiofrequency or cryoablation are controversial due to mixed results. Pulsed field ablation (PFA) is a novel AF ablation energy modality that has demonstrated preferential myocardial tissue ablation with a unique safety profile.
Objective: To compare sex differences in patients undergoing PFA for AF in the Multinational Survey on the Methods, Efficacy, and Safety on the Postapproval Clinical Use of Pulsed Field Ablation (MANIFEST-PF) registry.
J Cardiovasc Dev Dis
October 2023
Bordeaux University Hospital (CHU), Cardio-Thoracic Unit, F-33600 Bordeaux, France.
Background: Implantable cardioverter-defibrillators (ICDs) need to reliably detect ventricular tachycardia (VT) and ventricular fibrillation (VF) while avoiding T-wave oversensing (TWOS), which is associated with a risk of inappropriate therapies. The incidence of TWOS with endovascular ICDs appears to differ between manufacturers.
Objectives: We aimed to evaluate the incidence and clinical consequences of TWOS with contemporary Medtronic and Boston Scientific ICDs.
Pacing Clin Electrophysiol
December 2023
Department of Cardiology, University Hospital Rangueil, Toulouse, France.
Background: Efficiency and safety of ablation using half normal saline (HNS) has been shown in refractory ventricular tachycardia (VT), but no evaluation in unselected larger populations has been made.
Objective: To evaluate the efficiency and safety of systematic HNS ablation in VT ablation.
Methods: All successive VT ablations in patients with structural heart disease from 2018 to 2021 used HNS in our center and were retrospectively included.
Eur J Vasc Endovasc Surg
February 2024
Department of Vascular Surgery, University Hospital Rangueil, Toulouse, France.
Eur Radiol
December 2023
Department of Radiology, Sorbonne Université, AP-HP, Hôpital Tenon, Paris, France.
Purpose: To compare the oncological and perioperative outcomes of robot-assisted partial nephrectomy (RPN) and percutaneous thermal ablation (PTA) for treatment of T1 renal cell cancer (RCC) in patients older than 75 years.
Materials And Methods: Retrospective national multicenter study included all patients older than 75 years treated for a T1 RCC by RPN or PTA between January 2010 and January 2021. Patients' characteristics, tumor data, and perioperative and oncological outcomes were compared.
Amyloid
December 2023
Pfizer Inc., New York, NY, USA.
Heart Rhythm
October 2023
Cardio-Thoracic Unit, Bordeaux University Hospital (CHU), Pessac, France; IHU Liryc, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Université de Bordeaux, Pessac- Bordeaux, France.
Background: Pacemakers (PMs) and implantable cardioverter-defibrillators (ICDs) increasingly automatically record and remotely transmit nonsustained ventricular tachycardia (NSVT) episodes, which may reveal ventricular oversensing.
Objectives: We aimed to develop and validate a machine learning algorithm that accurately classifies NSVT episodes transmitted by PMs and ICDs in order to lighten health care workload burden and improve patient safety.
Methods: PMs or ICDs (Boston Scientific, St Paul, MN) from 4 French hospitals with ≥1 transmitted NSVT episode were split into 3 subgroups: training set, validation set, and test set.
Eur J Vasc Endovasc Surg
October 2023
Department of Vascular Surgery, Toulouse University Hospital, Toulouse, France.
Objective: The aim of this study was to compare the long term efficacy of lower limb bypass with that of endovascular treatment (EVT) in patients with chronic limb threatening ischaemia (CLTI).
Methods: This retrospective, multicentre study evaluated the outcomes of patients with CLTI who underwent first time infra-inguinal bypass or EVT. The primary outcome was to compare amputation free survival (AFS) rates between the two propensity score matched groups.